<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04487938</url>
  </required_header>
  <id_info>
    <org_study_id>thomsonp@hku.hk</org_study_id>
    <nct_id>NCT04487938</nct_id>
  </id_info>
  <brief_title>Oral Cancer Screening and Education in Hong Kong</brief_title>
  <official_title>THE HONG KONG ORAL CANCER EDUCATION AND SCREENING (HOCES) PROGRAM: REFINING DISEASE PREVENTION, RISK STRATIFICATION AND EARLY DETECTION</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted to obtain data on oral cancer risk factors to generate machine
      learning models with good predictive accuracy for stratifying individuals with high-oral
      cancer risk and delineating high-risk and low-risk oral lesions. Likewise, this study will
      seek to provide oral cancer-related health education and training on oral-self-examination
      for beneficiaries
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of machine learning algorithms for predicting high-risk persons</measure>
    <time_frame>24 months</time_frame>
    <description>Predictive accuracy of the ML classifiers for forecasting individuals with or likely to develop high-risk lesions within 24 months of first screening encounter based on demographic and lifestyle information.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Accuracy of machine learning algorithms for discriminating high-risk and low-risk lesions</measure>
    <time_frame>24 months</time_frame>
    <description>Predictive accuracy of ML classifiers for classifying high-risk and low-risk lesions based on demographic and lifestyle risk factors, oral high-risk HPV status, and salivary DNA hypermethylation levels.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3190</enrollment>
  <condition>Oral Cancer</condition>
  <condition>Oral Leukoplakia</condition>
  <condition>Oral Submucous Fibrosis</condition>
  <condition>Proliferative Verrucous Leukoplakia</condition>
  <condition>Oral Erythroplakia</condition>
  <condition>Erosive Lichen Planus</condition>
  <arm_group>
    <arm_group_label>Tobacco use and/or alcohol consumption</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>No tobacco use and/or alcohol consumption</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention utilised</intervention_name>
    <description>No intervention utilised</description>
    <arm_group_label>No tobacco use and/or alcohol consumption</arm_group_label>
    <arm_group_label>Tobacco use and/or alcohol consumption</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Oral rinse samples obtained via drooling in 50cc tubes.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Hong Kong residents aged 45 years and above residing in Southern and Central and Western
        district council districts (DCD).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy individuals satisfying age and residential area criteria with no previous
             history of oral cancer. Individuals with a history of other cancers will be included
             in the study provided they have been in remission for more than three years.

        Exclusion Criteria:

          -  Participants with reduced mouth opening (irrespective of the cause) to permit proper
             administration of VOE or photosensitive epilepsy will be excluded. Likewise, those who
             decline the provision of written consent or participation in any part of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Thomson</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John Adeoye</last_name>
    <phone>56441784</phone>
    <email>jaadeoye@hku.hk</email>
  </overall_contact>
  <reference>
    <citation>Adeoye J, Choi SW, Thomson P. Bayesian disease mapping and the 'High-Risk' oral cancer population in Hong Kong. J Oral Pathol Med. 2020 May 25. doi: 10.1111/jop.13045. [Epub ahead of print]</citation>
    <PMID>32450000</PMID>
  </reference>
  <reference>
    <citation>Adeoye J, Brennan PA, Thomson P. &quot;Search less, verify more&quot;-Reviewing salivary biomarkers in oral cancer detection. J Oral Pathol Med. 2020 Feb 6. doi: 10.1111/jop.13003. [Epub ahead of print] Review.</citation>
    <PMID>32027406</PMID>
  </reference>
  <reference>
    <citation>Adeoye J, Chu CS, Choi SW, Thomson P. Oral cancer awareness and individuals' inclination to its screening and risk prediction in Hong Kong. J Cancer Educ. 2020.</citation>
  </reference>
  <reference>
    <citation>Adeoye J, Thomson P. Strategies to improve diagnosis and risk assessment for oral cancer patients. Faculty Dental Journal. 2020;11(3):122-7.</citation>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 22, 2020</study_first_submitted>
  <study_first_submitted_qc>July 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2020</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Professor Peter James Thomson</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth Neoplasms</mesh_term>
    <mesh_term>Lip Neoplasms</mesh_term>
    <mesh_term>Leukoplakia</mesh_term>
    <mesh_term>Leukoplakia, Oral</mesh_term>
    <mesh_term>Oral Submucous Fibrosis</mesh_term>
    <mesh_term>Lichen Planus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

